Clinical Trial Update: Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating uridine supplementation in HIV-infected adults with lipoatrophy; results completed and posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Lipoatrophy

Drugs mentioned

• uridine supplementation (uridine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Lipoatrophy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-10-04